Ignite Creation Date:
2024-05-06 @ 7:05 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05899816
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-07
First Post:
2023-06-02
Brief Title:
A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis AD ROCKET - VOYAGER
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-11-06
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-02
First Submit QC Date:
June 2 2023
Study First Post Date:
2023-06-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-11
Last Update Post Date:
2024-03-07
Last Update Post Date Type:
ACTUAL